Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations
PaperCitations, authors & open-access status
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 84 citations, 2023 year and green oa status.
84
Citations
2023
Year
green
OA Status